Skip to main content
Victoria Seewaldt, MD, Oncology, South Pasadena, CA, City of Hope Comprehensive Cancer Center

VictoriaLouiseSeewaldtMD

Oncology South Pasadena, CA

Breast Cancer

Professor

Dr. Seewaldt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Seewaldt's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1992 - 1995
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1990 - 1992
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 1989

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2015 - 2025
  • NC State Medical License
    NC State Medical License 2000 - 2016
  • OH State Medical License
    OH State Medical License 1998 - 2000
  • WA State Medical License
    WA State Medical License 1989 - 1999

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Racial, Economic Segregation Linked to Cancer Mortality
    Racial, Economic Segregation Linked to Cancer MortalityNovember 17th, 2022
  • National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory Board
    National Cancer Center Is Pleased to Name David Knorr, M.D., Ph.D., to Scientific Advisory BoardOctober 25th, 2022
  • National Cancer Center Announces Recipients of 2021-22 Research Fellowship Awards
    National Cancer Center Announces Recipients of 2021-22 Research Fellowship AwardsJune 16th, 2021
  • Join now to see all

Grant Support

  • Targeted Chemoprevention Of Breast Cancer: From The Bench To Clinical TestingNational Cancer Institute2012
  • KCNK9 Imprinting In Breast Cancer Progression And MetastasisNational Cancer Institute2011–2012
  • Molecular Markers Of Breast Cancer Risk And PreventionNational Cancer Institute2006–2010
  • Ecm-Mediated Apoptosis In P53 (-) HmecsNational Cancer Institute2006–2010
  • P53 Loss In Hmecs: A Model Of Breast Cancer PreventionNational Cancer Institute2003–2007
  • Extracellular Matrix Mediated Apoptosis In P53 (-) HmecsNational Cancer Institute2001–2005
  • RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1999
  • RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1998–1999
  • RAR Beta Mediated Apoptosis In Breast Cancer CellsNational Cancer Institute1995–1997

Hospital Affiliations